Medicare Enrolled

Dr. Hamza Beano, M.D.

Urology Physician · Royal Oak, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
31157 WOODWARD AVE, Royal Oak, MI 48073
2483361170
Registered in NPPES since 2014
NPI: 1396150306 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Beano from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Beano? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Beano

Dr. Hamza Beano is an urology physician in Royal Oak, MI, with 12 years of NPI registration. Based on federal Medicare data, Dr. Beano performed 1,701 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Beano received a total of $7,921 from 48 pharmaceutical and/or device companies across 183 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Beano is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years of NPI registration ▲ Top 31% volume in MI $7,921 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,701
Medicare services
Top 31% in MI for urology physician
Not available
Unique patients (not deduplicated)
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
311 $2 $10
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
281 $92 $235
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
259 $64 $92
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
231 $66 $160
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
146 $8 $41
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
90 $41 $59
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
87 $113 $354
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
75 $106 $200
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
44 $185 $575
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
25 $6 $6
Complete ultrasound of retroperitoneum
An ultrasound examination of the structures located behind the abdominal cavity.
25 $84 $339
Complete pelvic ultrasound
An imaging test using sound waves to create pictures of the organs and structures within the pelvis.
22 $75 $260
Limited ultrasound of pelvis
A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment.
22 $39 $173
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
18 $77 $233
Complex urodynamic pressure flow study
A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning.
16 $293 $1,018
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
15 $6 $180
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
12 $141 $275
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
11 $109 $386
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
11 $47 $172
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,921
Total received (2018-2024)
Avg $1,132/year across 7 years
Top 25% in MI for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
183
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,178
2023
$1,368
2022
$1,253
2021
$1,606
2020
$666
2019
$593
2018
$257

Payments by company (2024)

Agiliti Surgical, Inc.
$1,268
COLOPLAST CORP
$201
Sumitomo Pharma America, Inc.
$189
Olympus America Inc.
$53
UROGEN PHARMA, INC.
$52
Calyxo, Inc.
$48
ABBVIE INC.
$47
Dendreon Pharmaceuticals LLC
$47
Astellas Pharma US Inc
$43
Myriad Genetic Laboratories, Inc.
$42
Janssen Scientific Affairs, LLC
$42
Endo USA, Inc.
$41
PROGENICS PHARMACEUTICALS, INC.
$28
SUN PHARMACEUTICAL INDUSTRIES INC.
$16
ACCORD HEALTHCARE, INC.
$16
IMMUNITYBIO, INC.
$15
Tolmar, Inc.
$14
Tempus AI, Inc
$14
Top 3 companies account for 76.2% of 2024 payments
All-time payments by company (2018-2024) ›
Agiliti Surgical, Inc.
$1,295
BOSTON SCIENTIFIC CORPORATION
$1,127
Boston Scientific Corporation
$860
Coloplast Corp
$829
Astellas Pharma US Inc
$488
PROCEPT BioRobotics Corporation
$347
Sumitomo Pharma America, Inc.
$290
Olympus America Inc.
$223
Dendreon Pharmaceuticals LLC
$221
COLOPLAST CORP
$218
UROGEN PHARMA, INC.
$198
Antares Pharma, Inc.
$192
Innovation Technologies Inc
$170
Rochester Medical Corporation
$147
Myriad Genetic Laboratories, Inc.
$139
Endo Pharmaceuticals Inc.
$134
GlaxoSmithKline, LLC.
$122
AbbVie, Inc.
$81
Allergan, Inc.
$54
Calyxo, Inc.
$48
ABBVIE INC.
$47
C. R. Bard, Inc. & Subsidiaries
$45
Sun Pharmaceutical Industries Inc.
$45
TOLMAR Pharmaceuticals, Inc.
$44
Janssen Scientific Affairs, LLC
$42
Endo USA, Inc.
$41
Medtronic, Inc.
$36
UROVANT SCIENCES INC
$36
Janssen Biotech, Inc.
$34
180 Medical, Inc.
$33
Alnylam Pharmaceuticals Inc.
$32
PROGENICS PHARMACEUTICALS, INC.
$28
Bayer Healthcare Pharmaceuticals Inc.
$24
Blue Earth Diagnostics Limited
$22
AbbVie Inc.
$20
Laborie Medical Technologies Corp.
$20
GENZYME CORPORATION
$19
Photocure Inc
$18
Bayer HealthCare Pharmaceuticals Inc.
$17
Supernus Pharmaceuticals, Inc.
$17
SUN PHARMACEUTICAL INDUSTRIES INC.
$16
ACCORD HEALTHCARE, INC.
$16
Smith+Nephew, Inc.
$15
IMMUNITYBIO, INC.
$15
Tolmar, Inc.
$14
Tempus AI, Inc
$14
UroGen Pharma, Inc.
$14
SRS Medical Systems, Inc.
$13
Top 3 companies account for 41.4% of all-time payments
Associated products mentioned in payments ›
AMS · AMS 700 CXR RTE KIT · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · Altis · Axumin · BOTOX · BRACAnalysis CDx · Bard Urinary Drainage Bag · CAMCEVI · CVAC ASPIRATION SYSTEM · CYSVIEW · ELIGARD · ERLEADA · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GENERAL THERAPIES · GENERAL BPH · General - Erectile Dysfunction · INTERSTIM · IRRISEPT · JELMYTO · JEVTANA · LITHOVUE · LUPRON DEPOT · Lupron · MYRBETRIQ · Myrbetriq · NOCDURNA · Nubeqa · ORGOVYX · OXLUMO · PROLARIS · PROVENGE · PYLARIFY · Prolaris · REZUM · STRAVIX · Sonablate · Sonablate HIFU · SpeediCath · TACTRA · TITAN · TLANDO · Titan · UroCuff · Veozah · XIAFLEX · XYOSTED · Xofigo · Xtandi · YONSA · iTIND System · rezum Generator
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an urology physician in Royal Oak?
Compare urology physicians in the Royal Oak area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians in nearby ZIP areas
172
County median income
$95,296
Nearest hospital to ZIP centroid (approximate)
BEAUMONT HOSPITAL ROYAL OAK
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Beano is a clinical cardiology specialist, with moderate Medicare volume.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Beano experienced with automated urinalysis?
Based on Medicare claims data, Dr. Beano performed 311 automated urinalysis services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Beano receive payments from pharmaceutical companies?
Yes. Dr. Beano received a total of $7,921 from 48 companies across 183 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Beano's costs compare to other urology physicians in Royal Oak?
Dr. Beano's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Beano) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →